precancerous

(redirected from pre-neoplastic)
Also found in: Dictionary, Medical.

precancerous

(esp of cells) displaying characteristics that may develop into cancer

precancerous

[prē′kan·sə·rəs]
(pathology)
Pertaining to any pathological condition of a tissue which is likely to develop into cancer.
References in periodicals archive ?
All non- and pre-neoplastic lesions were included, while all neoplastic cases were excluded from the study.
Out of these, 195 (52%) cases were in non-neoplastic and pre-neoplastic category and 180 (48%) cases were neoplastic category.
Moreover, immune in- filtrates have not been previously correlated with pre-neoplastic and neoplastic breast tissues.
In this study, we have quantified immune cell infiltration (based on microscopy performed on H and E stained tissues) in pre-neoplastic, neoplastic and control breast tissues.
In the present experience, using pure BuAc diluted in drinking water, without sodium and esterification, was observed an important decrease of dysplastic lesions, considered pre-neoplastic lesions and histological markers of colon cancer, compared with the twofold found in sub-groups DMH-treated without BuAc supplementation.
The Institute for Clinical Systems Improvement guidelines on dyspepsia and GERD recommend that all patients aged [greater than or equal to] 50 years with symptoms of uncomplicated dyspepsia undergo upper endoscopy non-urgently because of the increased incidence of peptic ulcer disease, pre-neoplastic lesions, malignancy, and increased morbidity out of proportion to symptoms that are more common in an older patient population.
It is widely accepted that there are multistep molecular changes leading to malignant transformation from pre-neoplastic lesions to invasive tumors.
Appearance of pre-neoplastic foci was observed in both telomerase negative and telomerase positive mouse strains, indicating that pre-malignant lesions can form without telomerase.
In cases of "atypia of unknown significance" and "dysplasia," positivity for the marker should raise the possibility of CIS or pre-neoplastic change and identify those cases for follow-up.
These areas include prenatal testing where the TR-DNA test can be performed as early as 6 weeks of pregnancy; early tumor diagnosis including detection of pre-neoplastic conditions; tumor monitoring and detection of metastatic disease; assessment of anti-tumor therapies; and monitoring of transplanted, cells, tissues, and organs.